BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 37884011)

  • 1. Prior Cesarean Birth and Risk of Uterine Rupture in Second-Trimester Medication Abortions Using Mifepristone and Misoprostol: A Systematic Review and Meta-analysis.
    Henkel A; Miller HE; Zhang J; Lyell DJ; Shaw KA
    Obstet Gynecol; 2023 Dec; 142(6):1357-1364. PubMed ID: 37884011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uterine rupture in second-trimester misoprostol-induced abortion after cesarean delivery: a systematic review.
    Goyal V
    Obstet Gynecol; 2009 May; 113(5):1117-1123. PubMed ID: 19384128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Misoprostol for second trimester pregnancy termination in women with prior caesarean: a systematic review.
    Berghella V; Airoldi J; O'Neill AM; Einhorn K; Hoffman M
    BJOG; 2009 Aug; 116(9):1151-7. PubMed ID: 19438490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complications of second trimester induction for abortion or fetal demise for patients with and without prior cesarean delivery.
    Latta K; Barker E; Kendall P; Testani E; Laursen L; McClosky L; York S
    Contraception; 2023 Jan; 117():55-60. PubMed ID: 35760083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mifepristone-misoprostol dosing interval and effect on induction abortion times: a systematic review.
    Shaw KA; Topp NJ; Shaw JG; Blumenthal PD
    Obstet Gynecol; 2013 Jun; 121(6):1335-1347. PubMed ID: 23812471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical guidelines. Labor induction abortion in the second trimester.
    Borgatta L; Kapp N;
    Contraception; 2011 Jul; 84(1):4-18. PubMed ID: 21664506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical analyses of 66 cases of mid-trimester pregnancy termination in women with prior cesarean.
    Peng P; Liu XY; Li L; Jin L; Chen WL
    Chin Med J (Engl); 2015 Feb; 128(4):450-4. PubMed ID: 25673444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medical methods for mid-trimester termination of pregnancy.
    Wildschut H; Both MI; Medema S; Thomee E; Wildhagen MF; Kapp N
    Cochrane Database Syst Rev; 2011 Jan; 2011(1):CD005216. PubMed ID: 21249669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Uterine rupture during second trimester abortion with misoprostol.
    Nayki U; Taner CE; Mizrak T; Nayki C; Derin G
    Fetal Diagn Ther; 2005; 20(5):469-71. PubMed ID: 16113576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maternal complications associated with second trimester medical abortion using mifepristone priming and subsequent misoprostol.
    Dickinson JE; Doherty DA
    Contraception; 2023 Sep; 125():110080. PubMed ID: 37245784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Laparoscopic Management of Uterine Rupture After Early Second-Trimester Medical Abortion in a Patient With a Prior Cesarean Section.
    Namazov A; Grin L; Volodarsky M; Anteby E; Gemer O
    J Minim Invasive Gynecol; 2016; 23(6):862. PubMed ID: 27234883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mifepristone priming and subsequent misoprostol for second trimester medical abortion in women with previous caesarean delivery.
    Dickinson JE; Doherty DA
    Aust N Z J Obstet Gynaecol; 2023 Jun; 63(3):301-307. PubMed ID: 36789734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Use of misoprostol for induction of labor in case of fetal death or termination of pregnancy during second or third trimester of pregnancy: Efficiency, dosage, route of administration, side effects, use in case of uterine scar].
    Clouqueur E; Coulon C; Vaast P; Chauvet A; Deruelle P; Subtil D; Houfflin-Debarge V
    J Gynecol Obstet Biol Reprod (Paris); 2014 Feb; 43(2):146-61. PubMed ID: 24461423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surgical versus medical methods for second trimester induced abortion.
    Lohr PA; Hayes JL; Gemzell-Danielsson K
    Cochrane Database Syst Rev; 2008 Jan; (1):CD006714. PubMed ID: 18254113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rupture in an unscarred uterus during second trimester pregnancy termination with mifepristone and misoprostol.
    Bagga R; Chaudhary N; Kalra J
    Int J Gynaecol Obstet; 2004 Oct; 87(1):42-3. PubMed ID: 15464778
    [No Abstract]   [Full Text] [Related]  

  • 17. Late second-trimester abortions induced with mifepristone, misoprostol and oxytocin: a report of 428 consecutive cases.
    Esteve JL; Gallego FG; Llorente MP; Bermúdez SB; Sala ES; González LV; Texidó CS
    Contraception; 2008 Jul; 78(1):52-60. PubMed ID: 18555818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Self-administered versus provider-administered medical abortion.
    Gambir K; Kim C; Necastro KA; Ganatra B; Ngo TD
    Cochrane Database Syst Rev; 2020 Mar; 3(3):CD013181. PubMed ID: 32150279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uterine Scar Dehiscence Associated with Misoprostol Cervical Priming for Surgical Abortion: A Case Report.
    Stitely ML; Craw S; Africano E; Reid R
    J Reprod Med; 2015; 60(9-10):445-8. PubMed ID: 26592074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical application of low-dose misoprostol in the induced labor of 16 to 28 weeks pathological pregnancies (a STROBE-compliant article).
    Yang Y; Wang Y; Du X; Duan J; Huang YM
    Medicine (Baltimore); 2019 Oct; 98(40):e17396. PubMed ID: 31577749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.